Terms: = Uterine cancer AND TNFRSF14, Q92956, 8764, ENSG00000157873, TR2, ATAR, LIGHTR, HVEM, HVEA
3 results:
1. Immunologic Signatures across Molecular Subtypes and Potential Biomarkers for Sub-Stratification in Endometrial cancer.
Jiang F; Jiang S; Cao D; Mao M; Xiang Y
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675305
[TBL] [Abstract] [Full Text] [Related]
2. Prognosis Analysis and Validation of Fatty Acid Metabolism-Related lncRNAs and Tumor Immune Microenvironment in Cervical cancer.
Lang X; Huang C; Cui H
J Immunol Res; 2022; 2022():4954457. PubMed ID: 35942212
[TBL] [Abstract] [Full Text] [Related]
3. Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma.
Li S; Dong C; Chen J; Gao X; Xie X; Zhang X
Aging (Albany NY); 2021 Jun; 13(12):16696-16712. PubMed ID: 34158412
[TBL] [Abstract] [Full Text] [Related]
